Aehr Test Systems provides specialized test and burn-in solutions for semiconductors used in AI, data centers, automotive, and industrial sectors. Its fiscal year ends in late May, making the upcoming report for the fourth quarter and full fiscal 2026 ended May 29, 2026 particularly significant. Recent quarters have shown mixed revenue results alongside strong bookings driven by hyperscale AI customers. This earnings release offers the first comprehensive view of full-year performance and sets the stage for the new fiscal calendar alignment beginning in fiscal 2027. Results and forward commentary will help investors assess demand sustainability amid broader semiconductor industry cycles.
Consensus estimates and company guidance frame expectations for the upcoming release. For the full fiscal 2026 year, management previously guided revenue toward the upper end of the $45 million to $50 million range. Non-GAAP net loss per diluted share is projected between negative $0.13 and negative $0.09. In the third quarter ended February 27, 2026, the company reported revenue of $10.3 million and GAAP earnings per share of negative $0.10, which improved to negative $0.05 on a non-GAAP basis and beat analyst forecasts. Investors will monitor any refinements to these targets, updates on the $60 million to $80 million second-half bookings range, and details on follow-on production orders from key AI processor customers. Historical patterns show that positive bookings surprises have often supported stock performance around earnings announcements. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Heading into the July 14 release, investor sentiment reflects cautious optimism tied to AI infrastructure spending. Recent quarters have demonstrated resilience in bookings despite revenue variability, supporting a constructive tone among growth-oriented investors. Key risk factors include potential variability in quarterly revenue recognition and broader semiconductor capital spending trends. Market participants will watch for any post-announcement volatility driven by the quality of guidance updates and clarity on the fiscal year-end transition. Positive surprises in bookings or customer traction have historically helped stabilize or lift shares following similar reports.
Following the earnings release, attention will turn to guidance implications for fiscal 2027 and the impact of the calendar shift. The company is moving its fiscal year-end from late May to late June, creating a short transition period that will be reported separately. Investors should watch for updates on production order follow-through from hyperscale customers and any new design wins in silicon photonics or automotive applications.
Cost management and gross margin trends will also be important, given the company’s focus on scaling test solutions for high-volume AI devices. Demand signals from data center infrastructure spending remain a central theme, as does visibility into the previously highlighted $60 million to $80 million bookings range for the second half of fiscal 2026.
Broader industry dynamics, including semiconductor equipment spending cycles and competitive positioning in burn-in technology, will influence the longer-term trajectory. Monitoring these elements will help assess how AEHR positions itself amid evolving customer requirements.
In my analysis of stocks like this one, I often turn to specialized platforms to cross-check patterns and opportunities. Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. I find it particularly useful when evaluating how a name like AEHR stacks up against peers in the semiconductor space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
AEHR saw its Momentum Indicator move above the 0 level on September 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 77 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on September 18, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 30 of 37 cases over the following month. The odds of a continued upward trend are 81%.
AEHR moved above its 50-day moving average on September 18, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AEHR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +7.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 245 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Aroon Indicator entered an Uptrend today. In 201 of 230 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.663) is normal, around the industry mean (8.078). P/E Ratio (19.449) is within average values for comparable stocks, (161.623). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment